Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
Open Access
- 25 April 2023
- journal article
- research article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 13 (10) , 2653-2663
Abstract
The nebulization of alpha-1 antitrypsin (AAT) for its administration to the lung could be an interesting alternative to parenteral infusion for patients suffering from AAT genetic deficiency (AATD). In the case of protein therapeutics, the effect of the nebulization mode and rate on protein conformation and activity must be carefully considered. In this paper two types of nebulizers, i.e., a jet and a mesh vibrating system, were used to nebulize a commercial preparation of AAT for infusion and compared. The aerosolization performance, in terms of mass distribution, respirable fraction, and drug delivery efficiency, as well as the activity and aggregation state of AAT upon in vitro nebulization were investigated. The two nebulizers demonstrated equivalent aerosolization performances, but the mesh nebulizer provided a higher efficiency in the delivery of the dose. The activity of the protein was acceptably preserved by both nebulizers and no aggregation or changes in its conformation were identified. This suggests that nebulization of AAT represents a suitable administration strategy ready to be translated to the clinical practice for delivering the protein directly to the lungs in AATD patients, either as a support therapy to parenteral administration or for subjects with a precocious diagnosis, to prevent the onset of pulmonary symptoms. Graphical AbstractKeywords
Funding Information
- Regione Emilia-Romagna (PG/2015/731196)
- Università degli Studi di Parma
This publication has 42 references indexed in Scilit:
- The I-neb Adaptive Aerosol Delivery System Enhances Delivery of α1-Antitrypsin with Controlled InhalationJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiencyEuropean Respiratory Journal, 2009
- The influence of fluid physicochemical properties on vibrating-mesh nebulizationInternational Journal of Pharmaceutics, 2007
- α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patientsEuropean Respiratory Journal, 2006
- Peripheral deposition of α1‐protease inhibitor using commercial inhalation devicesEuropean Respiratory Journal, 2003
- Oxidation of either methionine super351 or methionine super358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activityJournal of Biological Chemistry, 2000
- Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.Journal of Clinical Investigation, 1989
- Replacement Therapy for Alpha1-Antitrypsin Deficiency Associated with EmphysemaNew England Journal of Medicine, 1987
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976